Skip to content

Nebivolol

Also called Bystolic

Highly beta-1 selective blocker that also stimulates nitric-oxide-mediated vasodilation.

  • TypeSmall molecule
  • FormOral
  • Researched forLongevity

Where to get Nebivolol

AlgoRx
Oral
Code CAMERON

Prescription route: a licensed provider decides whether it fits you.

Shop oral at AlgoRx

The short version

  • Why people research itMitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
  • What the evidence isApproved for hypertension, with the SENIORS trial (2,128 patients over 70) showing reduced death and cardiovascular hospitalization in elderly heart failure patients — notably including those with preserved ejection fraction, a group where little else has worked.
  • What to watchFainting, or a pulse that falls below about 45.

How Nebivolol works

Highly beta-1 selective blocker that also stimulates nitric-oxide-mediated vasodilation — the only beta blocker with that second mechanism.

Nebivolol is sold as one drug and is actually a 50:50 mixture of two molecules that do different things, and almost nothing written for patients says so. It is a racemate of d-nebivolol and l-nebivolol.

The vasodilator half is where the argument is, and the candidate receptor is beta-3. Beta-3 adrenoceptors on vascular endothelium couple to endothelial nitric oxide synthase; agonism there raises NO, which diffuses to smooth muscle, activates soluble guanylate cyclase, raises cyclic GMP and relaxes the vessel Dongdem 2024.

  • Oral

On the goal map: Endothelial function & nitric oxide (Heart, cholesterol & blood pressure)

Research on Nebivolol6 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: Approved for hypertension; the favorable metabolic profile rests on smaller trials.

Human clinical evidence

  • Approved for hypertension, with the SENIORS trial (2,128 patients over 70) showing reduced death and cardiovascular hospitalization in elderly heart failure patients — notably including those with preserved ejection fraction, a group where little else has worked.

  • Head-to-head hard-outcome superiority over older beta-blockers has not been demonstrated, despite the favorable mechanism. The metabolic and vasodilatory advantages are real on measurement and unproven on events.

Correlative data

  • Widely prescribed, and the beta-blocker most often chosen when the conventional ones cause problems. Less fatigue, less erectile dysfunction and less metabolic disturbance are the consistent real-world reports.

How the mechanism reads

  • The most beta-1 selective beta-blocker available, and it does something no other one does: it stimulates endothelial nitric oxide release through beta-3 activation, producing vasodilation.

    Mechanistic
  • That combination inverts the usual beta-blocker problem. Conventional beta-blockers raise peripheral resistance and worsen insulin sensitivity; adding NO-mediated vasodilation counteracts both.

    Mechanistic
  • High beta-1 selectivity also means minimal beta-2 blockade — the mechanism behind less bronchospasm and less interference with fat mobilization during training.

    Mechanistic

Sources

  • Duarte JD, et al. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy. Clinical Pharmacology and Therapeutics 2024 · PMID 38951961
  • Marques L, et al. New Data for Nebivolol after In Silico PK Study: Focus on Young Patients and Dosage Regimen. Pharmaceutics 2022 · PMID 36145659
  • Gungor G, et al. Nebivolol protects erectile functions compared to Metoprolol in hypertensive men with atherogenic, venogenic, psychogenic erectile dysfunction: A prospective, randomized, cross-over, clinical trial. European Journal of Internal Medicine 2022 · PMID 35752527
  • Wikananda IMF, et al. Effects of Nebivolol therapy on hemodynamic parameters and lipid profile compared to other beta blockers in patients with essential hypertension: a systematic review and meta-analysis. Caspian Journal of Internal Medicine 2024 · PMID 38463918
  • Dongdem JT, et al. The beta3-Adrenergic Receptor: Structure, Physiopathology of Disease, and Emerging Therapeutic Potential. Advances in Pharmacological and Pharmaceutical Sciences 2024 · PMID 39640497
  • Leander K, et al. CYP2D6-inhibiting drugs and risk of fall injury after newly initiated therapy with beta-blockers: a register-based case-crossover study. Scientific Reports 2025 · PMID 40640338

Nebivolol safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Pulse already under 50, sick sinus syndrome or heart block: a beta-1 blocker slows conduction further.
  • Severe asthma or active wheeze: selectivity fades at higher exposure and airways can tighten.
  • Insulin use or frequent low blood sugar: beta blockade hides the warning shakiness.
  • Fluoxetine, paroxetine or bupropion: they inhibit CYP2D6 and raise nebivolol levels sharply.
  • Pregnancy: beta blockers are linked to slower fetal growth.

What’s expected

  • Lower resting pulse and blood pressure, with the nitric-oxide arm adding vessel relaxation.
  • Tiredness and a lower exercise heart rate ceiling in the first weeks.
  • Cold hands and feet in some users.
  • Less pounding heartbeat feeling under stress.

Watch for

  • Fainting, or a pulse that falls below about 45.
  • Breathlessness lying flat or new ankle swelling.
  • Wheeze or chest tightness after starting.
  • Low-sugar episodes with no warning sweats or tremor.

Labs that tell you it’s working

  • Comprehensive Metabolic Panel (CMP)
  • Lipid Panel
  • HbA1c (Hemoglobin A1c)
  • Cystatin C with eGFR

Nebivolol is a beta-1 blocker that also stimulates nitric oxide release, so pulse, vessel tone and masked-hypoglycemia effects follow.

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

Nebivolol FAQ4 common questions

Is Nebivolol approved for human use?
Nebivolol is an approved medicine for the uses on its label. This page covers research beyond those uses, as education, not medical advice.
What is Nebivolol researched for?
Mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
Which labs show whether it's doing anything?
Comprehensive Metabolic Panel; Lipid Panel; HbA1c; Cystatin C with eGFR: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Nebivolol: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Nebivolol is. Skool covers how it is run.

Free on this page

What Nebivolol is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Nebivolol is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool